Sci Show: Curcumin showed in vitro antiviral activity against SARS-CoV-2, including the Delta variant. This antiviral effect, together with the observed immunomodulatory properties, suggests that curcumin could be a promising compound for the treatment of COVID-19 patients.

Wednesday, November 24, 2021

Curcumin showed in vitro antiviral activity against SARS-CoV-2, including the Delta variant. This antiviral effect, together with the observed immunomodulatory properties, suggests that curcumin could be a promising compound for the treatment of COVID-19 patients.

https://ift.tt/3CRKo86 via /r/science https://ift.tt/3l0yMK3

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)